Previous studies have shown that SOTs are inhibitors of Kelch‐like ECH‐associated protein 1 (KEAP1) and can activate Nrf2 signaling [8], but it appears the activation of this pathway happens at lower concentrations of SOTs and may not be related to 2P‐Im effects on MM cell viability. This evidence concerns the gene KEAP1 and Miyoshi myopathy.